Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: A population-based cohort study of breast cancer patients in Sweden

British Journal of Cancer

Volumn 95, Issue 1, 2006, Pages 118-122

  Chandanos, E ^a   Lindblad, M ^a   Jia, C ^a   Rubio, C A ^b   Ye, W ^a   Lagergren, J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenocarcinoma; Epidemiology; Gastric; Oesophagus; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CARDIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EXPOSURE; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SMOKING; STOMACH ADENOCARCINOMA; SWEDEN;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; RISK FACTORS; SMOKING; STOMACH NEOPLASMS; SWEDEN; TAMOXIFEN; TIME;

EID: 33745553524     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603214     Document Type: Article

References (24)

1. Andersson M, Storm HH, Mouridsen HT (1991) Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83: 1013-1017
2. Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7: 3-15
3. Cheng KK, Sharp L, McKinney PA, Logan RF, Chilvers CE, Cook-Mozaffari P, Ahmed A, Day NE (2000) A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 83: 127-132
4. Curtis RE, Boice JD, Jr, Shriner DA, Hankey BF, Fraumeni Jr JF (1996) Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst 88: 832-834
5. Fornander T, Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C, Skoog L, Somell A, Theve T, Wilking N, Hjalmar M-L (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1: 117-120
6. Fuchs CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333: 32-41
7. Harrison JD, Morris DL, Ellis IO, Jones JA, Jackson I (1989) The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma. Cancer 64: 1007-1010
8. Heuch I, Kvale G (2000) Menstrual and reproductive factors and risk of gastric cancer: a Norwegian cohort study. Cancer Causes Control 11: 869-874
9. Inoue M, Ito LS, Tajima K, Yamamura Y, Kodera Y, Takezaki T, Hamajima N, Hirose K, Kuroishi T, Tominaga S (2002) Height, weight, menstrual and reproductive factors and risk of gastric cancer among Japanese postmenopausal women: analysis by subsite and histologic subtype. Int J Cancer 97: 833-838
10. Kaneko S, Tamakoshi A, Ohno Y, Mizoue T, Yoshimura T (2003) Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control 14: 53-59
11. La Vecchia C, D'Avanzo B, Franceschi S, Negri E, Parazzini F, Decarli A (1994) Menstrual and reproductive factors and gastric-cancer risk in women. Int J Cancer 59: 761-764
12. Lagergren J, Jansson C (2005) Sex hormones and oesophageal adenocarcinoma: influence of childbearing? Br J Cancer 93: 859-861
13. Lagergren J, Nyren O (1998) Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers Prey 7: 913-915
14. Lindblad M, Garcia Rodriguez LA, Chandanos E, Lagergren J (2006a) Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer 94: 136-141
15. Lindblad M, Lindgren A, Ye W, Lagergren J (2006b) Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg 243: 479-485
16. Lindblad M, Rodriguez LA, Lagergren J (2005) Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 16: 285-294
17. Lindblad M, Ye W, Rubio C, Lagergren J (2004) Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev 13: 2203-2207
18. Matsuyama Y, Tominaga T, Nomura Y, Koyama H, Kimura M, Sano M, Miura S, Takashima S, Mitsuyama S, Ueo H, Ohashi Y (2000) Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol 11: 1537-1543
19. Palli D, Cipriani F, Decarli A, Galli M, Saieva C, Fraumeni Jr JF, Blot WJ, Buiatti E (1994) Reproductive history and gastric cancer among post-menopausal women. Int J Cancer 56: 812-815
20. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543
21. Plesko I, Preston-Martin S, Day NE, Tzonou A, Dimitrova E, Somogyi J (1985) Parity and cancer risk in Slovakia. Int J Cancer 36: 529-533
22. Rutqvist LE, Johansson H, Signomklao T, Johansson U, Fornander T, Wilking N (1995) : Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst 87: 645-651
23. Sipponen P, Correa P (2002) Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer 5: 213-219
24. Socialstyrelsen (2005) Cancer Incidence in Sweden 2003. Stockholm, Sweden: National Board of Health and Welfare, Cancer Registry